Correlation Histogram Type indication
With Array Biopharma earnings this week, the chance of another short squeeze increases, but so does your risk. Golden Cross on Daily, positive divergence on MACD, riding the upper Bollinger Band as of 8/2. My $ARRY upside target is $5.47 NASDAQ:ARRY
Weekly should cross zero line soon
Can't wait for ASCO
MACD, DMI, RSI & PSAR support signal this
Shorts need to cover, not enough shares. Earnings around the corner
Watch for key breaks
Mentioned a possible dead cat bounce on 12/14 playing out as expected
Price could bounce up to 4.50 from here where overhead supply will probably knock it ultimately down to $3.00
financial results for the second quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, February 3, 2015.
